Cambridge Healthtech Institute's 2nd Annual 

Patient-Centric Enrollment Planning and Engagement

Utilizing New Technology, Analytics and Outreach to Improve Patient Recruitment

17-18 September 2019

We are pleased to announce production of Cambridge Healthtech Institute’s Patient-Centric Enrollment Planning and Engagement conference being held 17-18 September 2019 at the Crowne Plaza Barcelona-Fira Center in Barcelona, Spain. Patient recruitment and up-front enrollment planning are critical to drug development programs, and if not adequately planned for or properly executed, can extend your development timeline by a number of years. Clinical researchers and study teams are working hard to better identify, understand, and engage patients. Developing both a patient-centric culture and systems is key to enrolling and retaining patients throughout the life of a clinical trial. There are strategies, new technologies and techniques to empower patients, improve outreach and better match trials to the patients who need them.

The gathering will be part of the Summit for Clinical Trials Operations Executives (SCOPE) Europe, a two-day event made up of shared plenary keynotes from biopharma thought leaders, five conference tracks focused on specific issues and functions within the clin ops, innovation and research enterprise, informal and interactive breakout discussion groups, and networking. Please see the overall program map below for 2019.

Final Agenda

Tuesday, 17 September

7:30 - 17:00 Registration Open

7:30 Morning Coffee


Opening Plenary Keynotes

10:00 Grand Opening Coffee Break in the Exhibit Hall


10:50 Chairperson’s Opening Remarks

Mark Summers, President, Patient Engagement, WCG

10:55 CASE STUDY: Look Who’s Talking – Patients!

Hartog_BertBert Hartog, PhD, Senior Director, Clinical Innovation, Janssen Pharmaceutica N.V.

It’s not just a trend, it’s a paradigm shift. It’s made its way across nearly every industry and into millions of homes. We’re talking Voice-Enabled Technology. VET holds the power to reshape business and can redefine the clinical trial experience. Results from a pioneering study evaluating a voice-activated application in a real-life clinical setting will be presented. These will help researchers understand how patients with rheumatic diseases interact with VET and their preferences for using it.

11:20 CASE STUDY: Share4Rare: Digital Innovative Platform for Citizen Science in Rare Diseases

Nafra_BegonyaBegonya Nafria Escalera, Patient Engagement in Research Coordinator, Clinical Research Unit, Sant Joan de Deu Barcelona Children's Hospital, Research Foundation Barcelona Children's Hospital

Share4Rare (S4R) is a collective online platform with the ambition to make a difference for rare disease patients and their families. In the enabling S4R environment, patients and families are in direct contact with researchers and clinicians to become researchers of their own disease. Interactive platforms will break isolation and allow learning across rare conditions, so that being rare no longer means being alone.

11:45 CO-PRESENTATION: Patient Centricity: Translating Intention into Action

Evett_SophieSophie Evett, Feasibility Lead, Study Optimization, Global Product Development, Pfizer

Powell_GarethGareth Powell, Business Operations, Research Delivery, National Institute for Health Research (NIHR) Clinical Research Network Coordinating Centre

Meaningful patient and public involvement and engagement in clinical research design and delivery has been taking place across England for the decade, but it has often been regional or localised to specific institutions or disease areas. The UK is now realising the ambition of implementing a national framework for patient involvement with a clear route for life science companies to engage with relevant patients who can help shape clinical trial design and delivery at the earliest possible opportunity. This requires meaningful involvement at the protocol design stage, not just at the patient information leaflet stage. This presentation will describe a collaboration to design, develop and pilot a network approach to connecting companies and patients who are willing and able to contribute at the protocol design stage.

12:10 Patient Centric Supply Models – How to Successfully Implement Direct to Patient Services

Finn_KimKim Finn, Vice President, Global Patient Centric Services, Commercial Operations, Marken

Topics to be discussed include: 1) Industry update 2) How Direct to Patient can support Enrollment and Engagement 3) Challenges, Lessons learned, How to Ensure Success 4) What to consider when thinking about Direct to Patient.

12:35 Lunch in the Exhibit Hall (Community Networking)

Integrating Patient Insights in Protocol Design & Better Predicting/Delivering Recruitment

13:55 Chairperson’s Remarks

Sophie Evett, Feasibility Lead, Study Optimization, Global Product Development, Pfizer

14:00 CASE STUDY: Simulation in Paediatric Clinical Trials

Claverol_JoanaJoana Claverol Torres, Clinical Trials Unit Coordinator, Sant Joan de Deu Barcelona Children's Hospital, Research Foundation Barcelona Children's Hospital

Simulation of the different activities to be performed during a trial with patients is a good opportunity to anticipate risks and to make adjustments in order to perform patient-centered projects. Sant Joan de Déu Children's Hospital has a dedicated unit for simulation activities. We will explain our experience in the administration of a trial with a radioactive medication, in order to anticipate security, logistic and quality of the clinical trial service. There is a lack of expertise in the implementation of simulation in the field of paediatric clinical trials. In the most complex situation it helps a lot to save time, resources and offer better quality for patient experience.

14:25 CASE STUDY CO-PRESENTATION: Tool and Method for Tracking Site and Patient Recruitment Performance and ROI Across All Vendors

O’Neill_BrendanBrendan O’Neill, Senior Director, Patient Recruitment Programs, Clinical Development & Operations, Global Product Development, Pfizer

LaLuna_LisaLisa La Luna, Senior Advisor, WCG

Pfizer has pioneered a technology and methodology to track site and patient recruitment performance and ROI across all vendors while leveraging the largest online destination for patient recruitment. We will share a streamlined solution that manages the internal ROI dynamics of the sponsor/site patient recruitment needs while leveraging the leading online patient ecosystem for clinical research to efficiently connect patients into appropriate clinical trials. This is a new and transformational solution to the challenges patient recruitment has faced for decades.

14:50 Flipping the Funnel in Patient Recruitment to Accelerate Enrollment Timelines

Summers_MarkMark Summers, President, Patient Engagement, WCG

Despite advances in science and technology, we still see that 80% of clinical trials are running behind on their enrollment timeline. Mark Summers shares his insights on the current industry model of patient recruitment and the philosophy behind the new patient recruitment paradigm. Things you will learn, include: shortcomings of the current industry model of patient recruitment, & how to better plan for and deploy patient recruitment strategies.  

GreenPhire 15:15 Overcoming Logistical Challenges to Participation in Global Clinical Trials

Murphy_JimJim Murphy, CEO, Greenphire

15:30 Refreshment Break in the Exhibit Hall


16:10 Find Your Table and Meet Your Moderator

16:15 Interactive Breakout Discussion Groups (Session #1)

17:00 Networking Reception in the Exhibit Hall

18:00 End of Day

Wednesday,18 September

8:00 Morning Coffee


8:30 Chairperson’s Remarks

Gareth Powell, Business Operations, Research Delivery, National Institute for Health Research (NIHR) Clinical Research Network Coordinating Centre

8:35 SPECIAL CASE STUDY: Operationalizing Patient-Centric Enrollment Using Digital Tech and Direct-to-Patient Models

Hersch_GregGreg Hersch, Head, Innovation, Global Development Operation, Novartis

Medicines can spend years in the development pipeline held back by a lack of suitable patients at clinical sites, yet we know the patients exist and are desperately waiting for the right medicines. Digital approaches can transform recruiting by adopting direct-to-patient models with these approaches enabling access to a wider pool of potential patients and the ability to explore new responses to diseases. We will share our vision for an end-to-end clinical trial recruitment capability based on a modular and partnership approach and also highlight the problems and pitfalls that that can be encountered when developing Outreach Electronica.

9:20 Patient Centricity on Trial

Evans_MarkMark Evans, Managing Director, Havas Lynx Faze

Clinical trials are broken and only patients can help us fix them. If we let them. We will explore how some of the world’s most innovative companies are bringing the patient experience front and centre in clinical trials, and reaping the benefits of doing so.

9:35 Efficient Patient Recruitment Strategies - Using Real World Patient Data for Successful Enrollment

Stadler_MichaelMichael Stadler, Mr. Co-Founder & President, CLARINESS

The use of real world patient data is a tool to better understand patient profiles, -location, availability and indication insights. Takeaways will be a deeper understanding about efficient use of RWD for patient enrollment; and learnings on timelines, challenges and success factors for planning recruitment and retention across multiple countries.

9:50 Coffee Break in the Exhibit Hall


10:35 Clinical Trial Information Accessibility: Improving the Quality and Utility of Clinical Trial Registration Data for Patients

Hodge_KeirKeir Hodge, Global Studies Leader, Global Clinical Operations, Hoffman La Roche

The Common Registry Data Packet (CRDP) is a TransCelerate initiative whose goal is to develop a catalog of the quality of existing registration data fields accompanied by guidance that will enable clinical trial sponsors to submit quality registration data that is both compliant to registry standards and presents high utility for patients. To ensure data quality is improved in a way that is beneficial to patients, CRDP's scope is limited to the registration data fields patients find most useful and informative on government-owned clinical trial registries. This session will share the key components of the CRDP catalog and how the initiative will ultimately improve the accessibility and value of clinical trial registries.

11:00 The Trials We Want: Clinical Trial Design from the Cancer Patient Perspective

Ryll_BettinaBettina Ryll, MD, PhD, Founder, Melanoma Patient Network Europe

Clinical trials in oncology provide treatment opportunities for patients with no other options. With stakes as high as survival, patients optimise their treatment strategies, with direct impact on trial recruitment and retention. MPNE, the Melanoma Patient Network Europe, has been educating Melanoma patients about scientific developments, clinical trials and innovative trial designs for more than 5 years and will share some of its learnings.

11:25 CASE STUDY: Digital Engagement to Better Reach and Retain Under-Represented Patients

Chopra_NarinderNarinder Chopra, Director, Feasibility, Enrollment & Retention Optimisation, Global Clinical Operations, Biogen

Incorporating digital tools to improve clinical trial infrastructure, participant outreach, enrollment, retention, and ultimately, outcomes, is a path the industry has been on for some time now. However, beyond the hype are some operational challenges that must be understood before investing in new tech or altering budgets/timelines with overly-optimistic expectations. This talk will share a specific application of digital engagement for under-represented patients.

11:50 NEW: INTERACTIVE PANEL: Patient Centered Technology in the Age of Virtualization - Focusing on the Patient and Technology Design

Costello_AnthonyModerator: Anthony Costello, Vice President, Mobile Health, Medidata

Hersch_GregPanelists: Greg Hersch, Head, Innovation, Global Development Operation, Novartis

Hartog_BertBert Hartog, PhD, Senior Director, Clinical Innovation, Janssen Pharmaceutica N.V.

Virtual Trials provide many benefits to patients including lowering patient burden, increased patient engagement, and lower out-of-pocket costs. A critical component of virtual trials is the patient experience when using digital tools during the conduct of a trial. This session reviews the use of virtualization technologies and the process by which the patient perspective is infused into the software development life cycle to create technical solutions that improve the overall patient experience.

12:15 Lunch in the Exhibit Hall (Community Networking)

13:25 Transition to Breakouts & Keynotes


13:35 Find Your Table and Meet Your Moderator

13:40 Interactive Breakout Discussion Groups (Session #2)

14:10 Clinical Research News’ European Innovations Awards & Closing Plenary Keynotes

15:25 Close of Conference


Clinical Research News European Innovations Awards

Clinical Research News' European Innovation Awards recognizes outstanding examples of applied strategic innovation—partnerships, deployments, and collaborations—that manifestly improve the clinical trial process. Submit your work:


Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

This year due to positive feedback we will be running two breakout discussion sessions, one on Tuesday afternoon and a second on Wednesday afternoon. Attendees will thus have a chance to join two topic discussions.

Please see details at:

For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
Phone: (+1) 541.482.4709

For partnering and sponsorship information, please contact:

Companies A-K:
Ilana Quigley
Sr. Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5457

Companies L-Z:
Patty Rose
Sr. Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.1349

For media and association partnerships, please contact:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5456